Stevens Capital Management LP Boosts Stake in Chemed Corp. (CHE)
Stevens Capital Management LP raised its stake in shares of Chemed Corp. (NYSE:CHE) by 45.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 10,454 shares of the company’s stock after purchasing an additional 3,280 shares during the quarter. Stevens Capital Management LP owned 0.07% of Chemed Corp. worth $2,112,000 as of its most recent filing with the SEC.
Several other large investors also recently bought and sold shares of the company. Chicago Equity Partners LLC increased its holdings in shares of Chemed Corp. by 80.2% during the 3rd quarter. Chicago Equity Partners LLC now owns 31,595 shares of the company’s stock worth $6,384,000 after purchasing an additional 14,065 shares during the period. Old Mutual Global Investors UK Ltd. boosted its position in shares of Chemed Corp. by 173.5% during the 3rd quarter. Old Mutual Global Investors UK Ltd. now owns 95,212 shares of the company’s stock valued at $19,237,000 after acquiring an additional 60,399 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Chemed Corp. by 1,504.5% during the 3rd quarter. IFP Advisors Inc now owns 706 shares of the company’s stock valued at $143,000 after acquiring an additional 662 shares in the last quarter. MCF Advisors LLC acquired a new stake in shares of Chemed Corp. during the 3rd quarter valued at about $152,000. Finally, Copeland Capital Management LLC boosted its position in shares of Chemed Corp. by 1.2% during the 3rd quarter. Copeland Capital Management LLC now owns 129,129 shares of the company’s stock valued at $26,091,000 after acquiring an additional 1,547 shares in the last quarter. Institutional investors own 97.29% of the company’s stock.
Several analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $216.00 target price on the stock in a research report on Monday, September 18th. National Bank Financial upgraded shares of Chemed Corp. from a “sector perform market weight” rating to an “outperform market weight” rating in a research report on Sunday, August 13th. KeyCorp assumed coverage on shares of Chemed Corp. in a research report on Monday, August 28th. They set a “sector weight” rating on the stock. Oppenheimer Holdings, Inc. lifted their target price on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Thursday, July 27th. Finally, TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of C$236.00.
Shares of Chemed Corp. (CHE) opened at C$231.12 on Friday. The firm has a market cap of $3,690.06, a PE ratio of 28.46, a PEG ratio of 4.89 and a beta of 1.14. Chemed Corp. has a 12-month low of C$143.87 and a 12-month high of C$235.96. The company has a current ratio of 0.50, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings results on Thursday, October 26th. The company reported C$2.15 EPS for the quarter, beating the Zacks’ consensus estimate of C$2.00 by C$0.15. The firm had revenue of C$417.40 million for the quarter, compared to analyst estimates of C$414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.73 earnings per share. analysts anticipate that Chemed Corp. will post 4.73 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, December 4th. Shareholders of record on Monday, November 13th will be given a $0.28 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.12 dividend on an annualized basis and a yield of 0.48%. Chemed Corp.’s dividend payout ratio (DPR) is presently 24.89%.
In other Chemed Corp. news, VP Naomi C. Dallob sold 1,900 shares of the business’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of C$231.00, for a total value of C$438,900.00. Following the transaction, the vice president now directly owns 10,426 shares in the company, valued at C$2,408,406. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of C$228.45, for a total transaction of C$228,450.00. Following the completion of the transaction, the executive vice president now owns 36,809 shares in the company, valued at C$8,409,016.05. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,650 shares of company stock worth $3,480,193. Company insiders own 4.90% of the company’s stock.
Chemed Corp. Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.